Asia-Pacific Viral Vector Purification Market to 2032
Overview
The Asia-Pacific Viral Vector Purification Market is expected to reach a 471.25 USD Million by 2032 and is projected to grow at a CAGR of 25.15% from 2025 to 2032.
Revenue, 2024 (USD Million)
148.67
Forecast, 2032 (USD Million)
471.25
CAGR, 2024 - 2032
25.15%
Report Coverage
Asia-Pacific
Asia-Pacific Viral Vector Purification Market 2018-2032 USD Million
Asia-Pacific Viral Vector Purification Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 148.67 USD Million
- Projected Market Size (2032): 471.25 USD Million
- CAGR (2025-2032): 25.15%
Key Findings of Asia-Pacific Viral Vector Purification Market
- The Asia-Pacific Viral Vector Purification Market was valued at 148.67 USD Million in 2024.
- The Asia-Pacific Viral Vector Purification Market is likely to grow at a CAGR of 25.15% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Upstream Processing in Workflow Segment accounted for the largest share of the market with a revenue of 131.98 USD Million
- The fastest growing segment Chromatography in Purification Technique Segment grew Fastest with a CAGR of 28.13% during the forecast period from 2024 to 2032.
Asia-Pacific Viral Vector Purification Market Scope
Asia-Pacific Viral Vector Purification Market Segmentation & Scope
By Type
- Vaccine Virus
- Retroviral Vectors
- Other
- Lentivirus
- Adenoviral Vectors
- Adeno-Associated Viral Vectors
Workflow
- Downstream Processing
- Upstream Processing
Scale of Operation
- Commercial
- Preclinical / Clinical
Delivery Mode
- Ex Vivo
- In Vivo
Disease Indication
- Other
- Cancer
- Veterinary Disease
- Infectious Diseases
- Genetic Disorders
Product & Services
- Services
- Products
Purification Technique
- Two-Phase Extraction Systems
- Precipitation
- Ultrafiltration
- Density-Gradient Ultracentrifugation
- Chromatography
Application
- Antisense & RNAI
- Vaccinology
- Cell Therapy
- Gene Therapy
End User
- Contract Research Organizations
- Biotechnology Companies
- Contract Development And Manufacturing Organization (CDMO)
- Pharmaceutical Companies
- Academic/ Research Institutes
Asia-Pacific Viral Vector Purification Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 148.67 USD Million |
| Market Value in 2032 | 471.25 USD Million |
| CAGR (2025-2032) | 25.15% |
| Historic Data | 2016-2023 |
| Market Segments Covered | By Type,Workflow,Scale of Operation,Delivery Mode,Disease Indication,Product & Services,Purification Technique,Application,End User |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 148.67 USD Million in 2024
- Key Country: Japan, leading in terms of revenue with value of 37.26 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Viral Vector Purification Market to 2032, By By Type
- Adeno-Associated Viral Vectors is the largest segment in Asia-Pacific Viral Vector Purification Market to 2032 with a revenue of 77.57 USD Million in the year 2024.
- Lentivirus is the Fastest growing segment in Asia-Pacific Viral Vector Purification Market to 2032 with a Growth rate of 25.61 % in forecast period 2025-2032.
-
Asia-Pacific Viral Vector Purification Market to 2032, By Workflow
- Upstream Processing is the largest segment in Asia-Pacific Viral Vector Purification Market to 2032 with a revenue of 131.98 USD Million in the year 2024.
- Upstream Processing is the Fastest growing segment in Asia-Pacific Viral Vector Purification Market to 2032 with a Growth rate of 25.48 % in forecast period 2025-2032.
-
Asia-Pacific Viral Vector Purification Market to 2032, By Scale of Operation
- Preclinical / Clinical is the largest segment in Asia-Pacific Viral Vector Purification Market to 2032 with a revenue of 89.33 USD Million in the year 2024.
- Preclinical / Clinical is the Fastest growing segment in Asia-Pacific Viral Vector Purification Market to 2032 with a Growth rate of 26.87 % in forecast period 2025-2032.
-
Asia-Pacific Viral Vector Purification Market to 2032, By Delivery Mode
- In Vivo is the largest segment in Asia-Pacific Viral Vector Purification Market to 2032 with a revenue of 96.47 USD Million in the year 2024.
- In Vivo is the Fastest growing segment in Asia-Pacific Viral Vector Purification Market to 2032 with a Growth rate of 26.55 % in forecast period 2025-2032.
-
Asia-Pacific Viral Vector Purification Market to 2032, By Disease Indication
- Genetic Disorders is the largest segment in Asia-Pacific Viral Vector Purification Market to 2032 with a revenue of 83.36 USD Million in the year 2024.
- Infectious Diseases is the Fastest growing segment in Asia-Pacific Viral Vector Purification Market to 2032 with a Growth rate of 25.97 % in forecast period 2025-2032.
-
Asia-Pacific Viral Vector Purification Market to 2032, By Product & Services
- Products is the largest segment in Asia-Pacific Viral Vector Purification Market to 2032 with a revenue of 110.17 USD Million in the year 2024.
- Products is the Fastest growing segment in Asia-Pacific Viral Vector Purification Market to 2032 with a Growth rate of 26.15 % in forecast period 2025-2032.
-
Asia-Pacific Viral Vector Purification Market to 2032, By Purification Technique
- Chromatography is the largest segment in Asia-Pacific Viral Vector Purification Market to 2032 with a revenue of 75.07 USD Million in the year 2024.
- Chromatography is the Fastest growing segment in Asia-Pacific Viral Vector Purification Market to 2032 with a Growth rate of 28.13 % in forecast period 2025-2032.
-
Asia-Pacific Viral Vector Purification Market to 2032, By Application
- Gene Therapy is the largest segment in Asia-Pacific Viral Vector Purification Market to 2032 with a revenue of 75.75 USD Million in the year 2024.
- Gene Therapy is the Fastest growing segment in Asia-Pacific Viral Vector Purification Market to 2032 with a Growth rate of 27.61 % in forecast period 2025-2032.
-
Asia-Pacific Viral Vector Purification Market to 2032, By End User
- Academic/ Research Institutes is the largest segment in Asia-Pacific Viral Vector Purification Market to 2032 with a revenue of 72.65 USD Million in the year 2024.
- Academic/ Research Institutes is the Fastest growing segment in Asia-Pacific Viral Vector Purification Market to 2032 with a Growth rate of 26.31 % in forecast period 2025-2032.
Asia-Pacific Viral Vector Purification Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| Agilent Technologies, Inc. | |||
| FUJIFILM Diosynth Biotechnologies | |||
| Cytiva | |||
Asia-Pacific Viral Vector Purification Market Geographical Sales Distribution, 2018-2032 USD Million
Asia-Pacific Viral Vector Purification Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Viral Vector Purification Market is segmented based on Segmentation By Type,Workflow,Scale of Operation,Delivery Mode,Disease Indication,Product & Services,Purification Technique,Application,End User.
Asia-Pacific Viral Vector Purification Market was valued at USD 148.67(Revenue in USD Million) in 2020.
Asia-Pacific Viral Vector Purification Market is projected to grow at a CAGR of 25.15% during the forecast period of 2024 to 2032.
The Upstream Processing segment is expected to dominate the Asia-Pacific Viral Vector Purification Market, holding a largest market share of 131.98 USD Million in 2024
Asia-Pacific Viral Vector Purification Market Scope
Asia-Pacific Viral Vector Purification Market Segmentation & Scope
By Type
- Vaccine Virus
- Retroviral Vectors
- Other
- Lentivirus
- Adenoviral Vectors
- Adeno-Associated Viral Vectors
Workflow
- Downstream Processing
- Upstream Processing
Scale of Operation
- Commercial
- Preclinical / Clinical
Delivery Mode
- Ex Vivo
- In Vivo
Disease Indication
- Other
- Cancer
- Veterinary Disease
- Infectious Diseases
- Genetic Disorders
Product & Services
- Services
- Products
Purification Technique
- Two-Phase Extraction Systems
- Precipitation
- Ultrafiltration
- Density-Gradient Ultracentrifugation
- Chromatography
Application
- Antisense & RNAI
- Vaccinology
- Cell Therapy
- Gene Therapy
End User
- Contract Research Organizations
- Biotechnology Companies
- Contract Development And Manufacturing Organization (CDMO)
- Pharmaceutical Companies
- Academic/ Research Institutes
Frequently Asked Questions
The Asia-Pacific Viral Vector Purification Market is segmented based on Segmentation By Type,Workflow,Scale of Operation,Delivery Mode,Disease Indication,Product & Services,Purification Technique,Application,End User.
Asia-Pacific Viral Vector Purification Market was valued at USD 148.67(Revenue in USD Million) in 2020.
Asia-Pacific Viral Vector Purification Market is projected to grow at a CAGR of 25.15% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Viral Vector Purification Market for final year is USD 471.25 (USD Million).
Asia-Pacific Viral Vector Purification Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Viral Vector Purification Market is segmented based on Segmentation By Type,Workflow,Scale of Operation,Delivery Mode,Disease Indication,Product & Services,Purification Technique,Application,End User.
Asia-Pacific Viral Vector Purification Market was valued at USD 148.67(Revenue in USD Million) in 2020.
Asia-Pacific Viral Vector Purification Market is projected to grow at a CAGR of 25.15% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Viral Vector Purification Market for final year is USD 471.25 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.